Episurf Medical: Strategy update to take the next commercial steps and improve financial results
Episurf Medical (Nasdaq: EPIS B) today announces that the company is implementing a strategic focus that brings an increased focus on the US market, as well as a transition to a distributor model for other key markets. The company sees great opportunities for continued commercialization within selected market segments. The strategic focus means: · Operational measures to significantly improve the company's financial position and running costs. · Accelerate the path towards, and increase transparency for, operational profitability. · Increased focus on distributor sales and